Rocco Venezia's most recent trade in Intercept Pharmaceuticals Inc was a trade of 16,000 Option to Purchase Common Stock done . Disclosure was reported to the exchange on Jan. 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 16,000 | 16,000 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 9,800 | 25,451 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. | 31 Dec 2022 | 675 | 15,651 (0%) | 0% | 12.4 | 8,350 | Common Stock |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.06 per share. | 01 Sep 2022 | 429 | 16,326 (0%) | 0% | 18.1 | 7,748 | Common Stock |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 6,100 | 6,100 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 3,600 | 16,755 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 01 Oct 2021 | 30 | 13,705 (0%) | 0% | 15.2 | 457 | Common Stock |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.05 per share. | 01 Sep 2021 | 524 | 13,735 (0%) | 0% | 15.0 | 7,886 | Common Stock |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 Jul 2021 | 30 | 14,259 (0%) | 0% | 20.5 | 614 | Common Stock |
| Intercept Pharmaceuticals Inc | Rocco Venezia | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. | 01 Apr 2021 | 29 | 14,289 (0%) | 0% | 24.3 | 704 | Common Stock |